Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3989532 | Journal of Thoracic Oncology | 2015 | 7 Pages |
Abstract
Initial progression of TKI-treated cancers occurred predominantly in original disease sites. Consolidation SBRT was judged feasible in a subset of patients following maximum TKI response and may have prevented oligoprogression in most of these. In addition, we hypothesize that consolidation SBRT for residual disease could delay subsequent metastatic reseeding.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hani MD, Karl MD, Subba R. MD, Andrzej PhD, Zofia MD, MPH, Henning MD, Lecia V. MD, MPH,